7
Thoracic Aortic Arteriosclerosis in Patients With Degenerative Aortic Stenosis With and Without Coexisting Coronary Artery Disease Sorel Goland, MD, Alfredo Trento, MD, Lawrence S. C. Czer, MD, Shervin Eshaghian, MD, Kirsten Tolstrup, MD, Tasneem Z. Naqvi, MD, Michele A. De Robertis, RN, James Mirocha, MS, Kiyoshi Iida, MD, and Robert J. Siegel, MD Division of Cardiology, Department of Cardiothoracic Surgery, Cedars-Sinai Medical Center, Los Angeles, California, and Department of Cardiology, Kaplan Medical Center, Israel Background. The association between the severity of arteriosclerosis in the thoracic aorta in patients with isolated aortic stenosis (AS) and with concomitant coro- nary artery disease (CAD) has been not evaluated. There- fore, the aim of our study was to compare the thoracic aortic atheroma extent and severity in patients with severe AS alone and with concomitant CAD by intraop- erative transesophageal echocardiography. Methods. We retrospectively evaluated echocardio- grams of 105 consecutive patients with severe degenera- tive AS who underwent aortic valve replacement. Sixty patients had concomitant CAD (AS/CAD) on coronary angiography and 45 had no CAD (AS alone). These patients were compared with 54 sex- and age-matched patients without AS or CAD. Aortic atheroma (localized intimal thickening of >3 mm) prevalence and morphol- ogy in three segments of aorta were assessed with echocardiography. Results. There were 62 men, mean age 75.3 9.4 years. No difference was observed in age, sex, and risk factors for arteriosclerosis other than hypercholesterolemia among AS/CAD, AS alone, and control groups (88%, 67%, 41%, respectively; p < 0.0001). The AS/CAD group had a significantly higher rate of aortic root calcification (68%, 36%, 26%, respectively; p < 0.0001) and aortic atheroma (ascending aorta [26%, 20%, 14%, respectively; p 0.03]; aortic arch [78%, 36%, 30%, respectively; p < 0.0001]; descending aorta [72%, 42%, 29%, respectively; p < 0.0001]) than AS alone or control subjects. Patients with AS/CAD also had more complex atheromas in the aortic arch (48%, 20%, 7%, respectively; p < 0.0001). Significant differences in extension of aortic arteriosclerosis (pres- ence of plaques in two or three segments) were observed among the groups (70%, 31%, 18%, respectively; p < 0.0001). Conclusions. Patients with severe AS and coexisting CAD have more extensive arteriosclerotic changes in the thoracic aorta compared with those with AS alone and control subjects. Preoperative evaluation of the thoracic aorta and more aggressive lipid therapy should be con- sidered in these patients. (Ann Thorac Surg 2008;85:113–9) © 2008 by The Society of Thoracic Surgeons D egenerative aortic stenosis (AS) is one of the most common valvular heart diseases, resulting in valve replacement [1, 2]. Recent studies have reported an association between aortic valve calcification and arterial arteriosclerosis, suggesting that the degenerative changes of the aortic valve leading to AS may be part of a similar arteriosclerotic process [3, 4]. Transesophageal echocardiography (TEE) allows accurate assessment of the degree of arteriosclerosis in the thoracic aorta [5–10]. The severity and extent of arteriosclerosis in the thoracic aorta are strong risk factors for ischemic stroke and for overall vascular risk [11–13]. The severity of aortic arte- riosclerosis has been shown to correlate with coronary artery disease (CAD). More recent studies have been demonstrated a link between arteriosclerotic changes in ascending aorta and AS. However, they did not look at the subset of patients with AS alone and those with coexisting CAD [14, 15]. It is still not clear whether CAD in patients with degenerative AS is associated with more extensive and severe arteriosclerosis of the thoracic aorta than patients with AS alone or patents without both these conditions. Therefore, we compared the presence and extent of thoracic aortic atheroma by intraoperative TEE in patients with severe degenerative AS with and without coexisting CAD, and matched control subjects having neither AS nor CAD. Patients and Methods We retrospectively evaluated TEEs of 105 consecutive patients with severe degenerative AS (tricuspid aortic Accepted for publication Aug 13, 2007. Address correspondence to Dr Siegel, Division of Cardiology, Room 5623, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048; e-mail: [email protected]. © 2008 by The Society of Thoracic Surgeons 0003-4975/08/$34.00 Published by Elsevier Inc doi:10.1016/j.athoracsur.2007.08.025 CARDIOVASCULAR

Thoracic Aortic Arteriosclerosis in Patients With Degenerative Aortic Stenosis With and Without Coexisting Coronary Artery Disease

Embed Size (px)

Citation preview

TDCSSMRDD

ainfase

gtpappioe

NaA

DraacaetTaor

A

ACe

©P

CA

RD

IOV

ASC

ULA

R

horacic Aortic Arteriosclerosis in Patients Withegenerative Aortic Stenosis With and Withoutoexisting Coronary Artery Disease

orel Goland, MD, Alfredo Trento, MD, Lawrence S. C. Czer, MD,hervin Eshaghian, MD, Kirsten Tolstrup, MD, Tasneem Z. Naqvi, MD,ichele A. De Robertis, RN, James Mirocha, MS, Kiyoshi Iida, MD, and

obert J. Siegel, MDivision of Cardiology, Department of Cardiothoracic Surgery, Cedars-Sinai Medical Center, Los Angeles, California, and

epartment of Cardiology, Kaplan Medical Center, Israel

rs3(ad0Aadea0

Ctcas

Background. The association between the severity ofrteriosclerosis in the thoracic aorta in patients withsolated aortic stenosis (AS) and with concomitant coro-ary artery disease (CAD) has been not evaluated. There-ore, the aim of our study was to compare the thoracicortic atheroma extent and severity in patients withevere AS alone and with concomitant CAD by intraop-rative transesophageal echocardiography.Methods. We retrospectively evaluated echocardio-

rams of 105 consecutive patients with severe degenera-ive AS who underwent aortic valve replacement. Sixtyatients had concomitant CAD (AS/CAD) on coronaryngiography and 45 had no CAD (AS alone). Theseatients were compared with 54 sex- and age-matchedatients without AS or CAD. Aortic atheroma (localized

ntimal thickening of >3 mm) prevalence and morphol-gy in three segments of aorta were assessed withchocardiography.Results. There were 62 men, mean age 75.3 � 9.4 years.o difference was observed in age, sex, and risk factors for

rteriosclerosis other than hypercholesterolemia among

S/CAD, AS alone, and control groups (88%, 67%, 41%,

adatcietceicn

P

Wp

edars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048;-mail: [email protected].

2008 by The Society of Thoracic Surgeonsublished by Elsevier Inc

espectively; p < 0.0001). The AS/CAD group had aignificantly higher rate of aortic root calcification (68%,6%, 26%, respectively; p < 0.0001) and aortic atheromaascending aorta [26%, 20%, 14%, respectively; p � 0.03];ortic arch [78%, 36%, 30%, respectively; p < 0.0001];escending aorta [72%, 42%, 29%, respectively; p <.0001]) than AS alone or control subjects. Patients withS/CAD also had more complex atheromas in the aortic

rch (48%, 20%, 7%, respectively; p < 0.0001). Significantifferences in extension of aortic arteriosclerosis (pres-nce of plaques in two or three segments) were observedmong the groups (70%, 31%, 18%, respectively; p <.0001).Conclusions. Patients with severe AS and coexisting

AD have more extensive arteriosclerotic changes in thehoracic aorta compared with those with AS alone andontrol subjects. Preoperative evaluation of the thoracicorta and more aggressive lipid therapy should be con-idered in these patients.

(Ann Thorac Surg 2008;85:113–9)

© 2008 by The Society of Thoracic Surgeons

egenerative aortic stenosis (AS) is one of the mostcommon valvular heart diseases, resulting in valve

eplacement [1, 2]. Recent studies have reported anssociation between aortic valve calcification and arterialrteriosclerosis, suggesting that the degenerativehanges of the aortic valve leading to AS may be part ofsimilar arteriosclerotic process [3, 4]. Transesophageal

chocardiography (TEE) allows accurate assessment ofhe degree of arteriosclerosis in the thoracic aorta [5–10].he severity and extent of arteriosclerosis in the thoracicorta are strong risk factors for ischemic stroke and forverall vascular risk [11–13]. The severity of aortic arte-iosclerosis has been shown to correlate with coronary

ccepted for publication Aug 13, 2007.

ddress correspondence to Dr Siegel, Division of Cardiology, Room 5623,

rtery disease (CAD). More recent studies have beenemonstrated a link between arteriosclerotic changes inscending aorta and AS. However, they did not look athe subset of patients with AS alone and those withoexisting CAD [14, 15]. It is still not clear whether CADn patients with degenerative AS is associated with morextensive and severe arteriosclerosis of the thoracic aortahan patients with AS alone or patents without both theseonditions. Therefore, we compared the presence andxtent of thoracic aortic atheroma by intraoperative TEEn patients with severe degenerative AS with and withoutoexisting CAD, and matched control subjects havingeither AS nor CAD.

atients and Methods

e retrospectively evaluated TEEs of 105 consecutive

atients with severe degenerative AS (tricuspid aortic

0003-4975/08/$34.00doi:10.1016/j.athoracsur.2007.08.025

vmItspad(apCtceapbslaowwMaVSorfifceliaitp

tmdtiswgtusaaiawesdp

SaSCwafvlpt

R

CAA

T

C

AMHDHCTTHLS

a

A CAD;d prote

114 GOLAND ET AL Ann Thorac SurgAORTIC ARTERIOSCLEROSIS IN AORTIC STENOSIS 2008;85:113–9

CA

RD

IOV

ASC

ULA

R

alve area �1 cm2) who underwent aortic valve replace-ent surgery (AVR). This study was approved by the

nstitutional Review Board at Cedars-Sinai Medical Cen-er with a waiver to obtain consent based on the retro-pective study nature and hiding of identification ofatient data. All patients are prospectively entered inton Institutional Review Board–certified quality assuranceatabase. Among all patients, 60 had concomitant CAD

AS/CAD) on coronary angiography (�50% coronaryrtery narrowing), and 45 had no CAD (AS/no CAD). Allatients with AS and each group according to presence ofAD were compared with 54 sex-and age-matched pa-

ients without AS (on echocardiography) or CAD (onoronary angiography or no evidence of inducible isch-mia on nuclear imaging). We defined diabetes mellituss hyperglycemia requiring pharmacologic therapy; hy-ertension as either a systolic or diastolic increase inlood pressure (�140/90 mm Hg) or use of antihyperten-ive therapy; hypercholesterolemia as a total cholesterolevel of greater than 200 mg/dL or use of lipid-loweringgents; and cigarette smoking as being an active smokerr having a history of smoking at least 10 pack-yearsithin the last 20 years. An HDI-5000 ultrasound systemith a 5-MHz TEE multiplane probe was used (Philipsedical System, Bothell, WA). Images were digitized,

nd off-line measurements were performed with theERICIS Echo Review application (Camtronics Medicalystems Inc, Hartland, WI). Transesophageal echocardi-graphy was performed in 105 patients as part of aoutine intraoperative TEE before and after AVR. Fifty-ve patients who make up the control group were re-

erred for TEE by their cardiologists as a part of thelinical work-up for different reasons such as suspectedndocarditis or atrial fibrillation, or evaluation of valvularesions other than AS. Transesophageal echocardiographymages were obtained using transgastric, midesophageal,nd basal views. All segments of the thoracic aorta,ncluding both the ascending and descending aorta andhe aortic arch, were evaluated for the presence of

able 1. Comparison of Baseline Characteristics and Arteriosc

haracteristic Control (n � 54)

ge (y) 72.3 � 10.2ales 65% (35)ypertension 62% (61)iabetes mellitus 18% (9)ypercholesterolemia 42% (22)holesterol-lowering treatment 34% (18)otal cholesterol (mg/dL) 164.4 � 33.5G (mg/dL) 119.8 � 52.3DL (mg/dL) 48.9 � 15.6DL (mg/dL) 90.9 � 32.0moking 33% (16)

p value for the comparison among the three groups.

S � aortic stenosis; AS/CAD � patients with AS and concomitantisease; HDL � high-density lipoprotein; LDL � low-density lipo

laques between angles of 0 and 90 degrees. Plaque v

hickness was defined as the thickness of the intima andedia layers of the walls measured perpendicularly

uring systole on a frozen frame. Maximum thickness ofhe plaques in each region was recorded. The aorticntima was evaluated for changes in thickening, protru-ion, mobile components, or ulceration. Aortic atheromaas defined as localized intimal thickening of 3 mm orreater. Complex lesions were plaques extending greaterhan 5 mm, or plaques that were protruding, mobile, orlcerated. Aortic atheroma score was calculated as theum of maximum plaque thickness of three segmentsnd was used to assess the severity and extent of aorticrteriosclerosis. Atheroma prevalence and morphologyn three segments of the aorta (ascending aorta, aorticrch, and descending aorta) were assessed. All TEEsere reviewed by one echocardiographer without knowl-

dge of CAD status. In addition, 40 randomly selectedtudies were interpreted independently by the echocar-iographer with excellent agreement (98%) about theresence or absence of thoracic aortic atheroma.Data are presented as mean � standard deviation.

tatistical analysis was performed using a commerciallyvailable statistical package (SPSS 12 statistical software;PSS Inc, Chicago, IL, or SAS version 9.1; SAS Institute,ary, NC). Comparisons across several different groupsere made by analysis of variance for continuous data

nd �2 tests (with Fisher’s exact test when appropriate)or categorical data. The significant baseline predictorariables were entered into a stepwise multivariableogistic regression model to predict aortic atheroma. Arobability value of less than 0.05 was considered statis-

ically significant.

esults

linical Characteristics and Risk Factorstotal of 105 patients with severe AS who underwent

VR (62 men, 59%; mean age, 75.3 � 9.4 years; aortic

is Risk Factors Among Three Groups

/No CAD (n � 45) AS/CAD (n � 60) p Valuea

74.8 � 9.9 75.6 � 9.0 0.249% (22) 67% (40) 0.159% (26) 65% (39) 0.827% (12) 33% (20) 0.267% (30) 88% (53) 0.00762% (28) 88% (53) 0.002

175.9 � 41.7 163.5 � 43.4 0.3109.1 � 56.6 117.6 � 49.8 0.658.0 � 23.3 54.4 � 16.7 0.292.4 � 34.8 85.6 � 37.4 0.653% (24) 56% (33) 0.04

AS/no CAD � patients with AS alone; CAD � coronary arteryin; TG � triglyceride.

leros

AS

alve area, 0.71� 0.24 cm2) and 54 age- and sex-matched

pPd1s(lwwoa

h(wmh

AT2co

Fa(wggspa

TA

V

AAAAA

A CADd

115Ann Thorac Surg GOLAND ET AL2008;85:113–9 AORTIC ARTERIOSCLEROSIS IN AORTIC STENOSIS

CA

RD

IOV

ASC

ULA

R

atients without AS and CAD constituted this study.atients with AS had a somewhat higher incidence ofiabetes mellitus than those without AS (31% versus8%; p � 0.08). There was a significant difference inmoking (54% versus 33%; p � 0.008), hyperlipidemia83% versus 42%; p � 0.0001), and the use of cholesterol-owering agents (77% versus 35%; p � 0.0001) in patientsith AS/CAD compared with AS alone. No differenceas found in age, sex, and risk factors for arteriosclerosisther than hyperlipidemia among AS/CAD, AS alone,nd control groups (Table 1). A higher incidence of

ig 1. (A) Comparison of prevalence of aortic atheroma in any segmemong three groups: patients with degenerative aortic stenosis (AS) wB) Comparison of aortic atheroma prevalence and morphology in theithout CAD and the control group. (C) Comparison of aortic atherom

roups: patients with degenerative AS with and without CAD and theroups: patients with AS with and without CAD and the control grouegments) has been measured in patients having atheroma (83% in Aatients). Probability values are for comparisons among the three gro

able 2. Prevalence of Aortic Atheroma Among Patients Withrtery Disease and the Control Group

ariable Control (n � 54

ortic root calcification 26% (14)ortic atheroma in any segment 42% (23)ortic atheroma in the ascending aorta 7% (4)ortic atheroma in the aortic arch 30% (16)ortic atheroma in the descending aorta 28% (15)

S � aortic stenosis; AS/CAD � patients with AS and concomitantisease.

scending aorta.)

yperlipidemia was found in patients with AS/CAD88%, 67%, 41%, respectively; p � 0.0001) than in thoseith AS alone or the control subjects, and subsequentlyore patients in the combined group were treated for

yperlipidemia (88%, 62%, 34%, respectively; p � 0.0001).

ortic Plaque Prevalence and Morphologyhe prevalence of aortic root calcification (54% versus6%; p � 0.008) was significant higher in patients with ASompared with control subjects as well as the prevalencef atheroma in the ascending aorta (24% versus 7%; p �

the thoracic aorta, aortic root calcification and ascending aortad without coronary artery disease (CAD) and the control group.

c arch among three groups: patients with degenerative AS with andevalence and morphology in the descending aorta among threerol group. (D) Comparison of aortic atheroma score among threertic atheroma score (the sum of maximum plaque thickness of threeD group, 62% in AS/no CAD group, and 44% in the control groupAo � aorta; Ao root Ca � aortic root calcification; Asc Ao �

enerative Aortic Stenosis With and Without Coronary

AS/No CAD (n � 45) AS/CAD (n � 60) p Value

36% (16) 68% (41) �0.000162% (28) 83% (50) 0.0420% (9) 27% (16) 0.0336% (16) 78% (47) �0.000142% (19) 72% (43) �0.0001

; AS/no CAD � patients with AS alone; CAD � coronary artery

nt ofith anaortia prcont

p. AoS/CAups. (

Deg

)

0idatTa02t2cihaHqprssAjbAdaapTastT

swrob

(4hAcm(fsg(emtp

pmwttddaaiwim

C

TCt(ceap

Frewcsaaj(hasv

116 GOLAND ET AL Ann Thorac SurgAORTIC ARTERIOSCLEROSIS IN AORTIC STENOSIS 2008;85:113–9

CA

RD

IOV

ASC

ULA

R

.0001), arch (60% versus 30%; p � 0.0001), and descend-ng aorta (59% versus 28%; p � 0.0001). Table 2 shows theifferences in the prevalence of aortic atheroma in anynd in each of the thoracic aorta segments among pa-ients with AS alone, AS/CAD, and control subjects. OnEE, the AS/CAD group had a significantly higher rate ofortic root calcification (68%, 36%, 26%, respectively; p �.0001) and aortic atheroma in the ascending aorta (26%,0%, 14%; p � 0.03), aortic arch (78%, 36%, 30%, respec-ively; p p � 0.0001), and the descending aorta (72%, 42%,9%, respectively; p � 0.0001) compared with AS alone orontrol patients. The comparison among the three groupss presented in Figure 1. Figure 1A shows a significantlyigher prevalence of aortic atheroma in the ascendingorta in the AS groups compared with the control group.owever, aortic root calcification was found more fre-uently in AS/CAD compared with both AS/no CADatients and control subjects (p � 0.001 and p � 0.0001,espectively). Figure 1B demonstrates that there is aignificantly higher prevalence of aortic atheroma, bothimple and complex, in the aortic arch in patients havingS/CAD compared with AS/no CAD and control sub-

ects. There were no significant differences obtainedetween control subjects and patients with AS/no CAD.s shown in Figure 1C, the same trend is present for theifferences in atheroma prevalence in the descendingorta. The overall prevalence of atheroma and the prev-lence of simple atheroma were higher in the AS/CADatients than in both AS/no CAD and control subjects.he prevalence of complex atheromas in the descendingorta was overall low and significantly lower in controlubjects than in patients with AS. Examples of variousypes of atheroma in the thoracic aorta by intraoperativeEE are shown in Figure 2.Significant differences in the extent of aortic arterio-

clerosis (presence of plaques in two or three segments)as found among the three groups (70%, 31%, 18%,

espectively; p � 0.0001). Aortic atheroma score (the sumf maximum plaque thickness of three segments) haseen measured in those patients who had atheroma

ig 2. Various types of atheroma in the tho-acic aorta evaluated by intraoperative trans-sophageal echocardiography in patientsith severe aortic stenosis and coexisting

oronary artery disease. The left top imagehows a protruding complex atheroma of theortic arch (arrow). The left bottom image isn example of a simple atheroma in theunction of aortic arch and descending aortaarrow). The right top image demonstratesighly mobile sessile atheroma in the aorticrch (arrow), and the right bottom imagehows multiple protruding atheromas withery thick aortic wall (arrow).

83.3% in AS/CAD, 62.2% in AS/no CAD groups, and4.4% in control group). Figure 1D shows significantlyigher aortic atheroma scores in patients with combinedS/CAD compared with both with AS/no CAD and

ontrol subjects. Finally, in patients with aortic athero-as significantly higher low-density lipoprotein levels

93.0 � 37.1 versus 73.1 � 29.5 mg/dL; p � 0.03) wereound compared with those without atheroma, with noignificant differences in total cholesterol (p � 0.3), tri-lycerides (p � 0.3), and high-density lipoprotein levelsp � 0.4). When the significant baseline variables werentered into a stepwise multivariable logistic regressionodel, CAD (odds ratio, 5.09; 95% confidence interval, 1.1

o 7.2; p � 0.02) was found to be the only predictor of theresence of aortic atheroma in patients with severe AS.Among 105 patients, 5 patients (4.7%) experienced a

erioperative stroke, and in 4 of them complex athero-as (3 of them protruding and mobile) in the aortic archere present on TEE. In all patients, brain computed

omography was obtained that verified cerebral infarc-ion. Three patients experienced unilateral hemiparesisuring the first 48 hours after surgery. In 1 patient a focaleficit (hemiplegia and aphasia) occurred immediatelyfter he awoke from anesthesia. One patient experiencedcute confusion state early after surgery with evidence ofnfarction on computed tomography. Among 38 patientsho had complex aortic arch atheroma on TEE, the

ncidence of postoperative stroke was 16%. The operativeortality was 0.9%.

omment

his study evaluated the association between coexistingAD and AS and the severity of atheromatous changes in

he aorta. Comparing two groups of patients with ASwith and without CAD) and the age- and sex-matchedontrol group, we were able to determine the impact ofach of these conditions on severity and extension ofrteriosclerotic changes in the thoracic aorta. Similar to arior report, we found that patients with severe AS had a

hts[warcAspApaarip

lirpirtisthtgasstc

pcmcodaroesppPnmbpaaai

pdTsdesopsiabtspwrcmsirtwtchdteisupcdaasTttamaalaaC(pctca

s

117Ann Thorac Surg GOLAND ET AL2008;85:113–9 AORTIC ARTERIOSCLEROSIS IN AORTIC STENOSIS

CA

RD

IOV

ASC

ULA

R

igher prevalence of arteriosclerotic changes in all por-ions of the thoracic aorta compared with the age- andex- matched control group with neither AS nor CAD15]. However, using the aortic atheroma scores, patientsith AS/CAD had significantly higher rates of aortic

theroma in all segments and more extensive arterioscle-otic changes compared with those with AS/no CAD andontrol subjects. In addition, patients with combinedS/CAD had significantly higher prevalence of both

imple and complex atheromas in the aortic arch, com-ared with those with AS/no CAD and control subjects.lthough no significant difference was found betweenatients with AS/no CAD and the control group, CADppears to be strongly associated with thoracic aorticrteriosclerosis. Using a stepwise multivariable logisticegression model, CAD was found to be the only signif-cant predictor of the presence of aortic atheroma inatients with severe AS.It has been demonstrated that aortic plaques are re-

ated to the presence and severity of CAD [16] and of thentimal thickening in the carotid artery [17]. In addition, aecent study found a strong association between theresence of AS and severity of aortic atheromas, suggest-

ng that AS might be a manifestation of the arterioscle-otic process [15]. Although a large number of patients inhis study had concomitant coronary artery bypass graft-ng, this study did not look at patients with isolated ASeparately. The difference in aortic arteriosclerosis be-ween patients with degenerative AS and bicuspid ASas been described, suggesting that the pathogenesis of

hese two diseases might be different [18]. Transesopha-eal echocardiography is an accurate method to assessrteriosclerotic plaques in the thoracic aorta and is con-idered to be the current noninvasive clinical “goldtandard.” Magnetic resonance imaging findings inerms of aortic plaque composition, extent, and sizelosely correlate with TEE [19].

A high incidence of perioperative stroke (25%) inatients with protruding atheromas has been reportedompared with those with less severe aortic arch athero-as (2%) [20]. In that study the intraoperative diagnosis

hanged the surgical approach in 8%, including changingf the site of cannulation or debridement of atheromauring circulatory arrest. The presence of complex aorticrch atheromas has been shown to increase the strokeate by sixfold after heart surgery [21]. In our study, 16%f patients with complex aortic arch experienced periop-rative stroke. The overall incidence of perioperativetroke in our study is 4.7% and was similar to previouslyublished data [15]. Of note, 4 of 5 of our patients witherioperative stroke had complex aortic arch atheromas.erioperative stroke has been mostly attributed to ma-ipulations of the ascending aorta during graft anasto-osis, cross-clamping, or cannulation with the “sand-

lasting effect” from the high-flow jet [22]. Therefore,atients with severe aortic arch arteriosclerosis representhigh risk for heart surgery with cannulation of the

ortic arch. The detection of complex aortic atheromasnd choice of the surgical approach can reduce the

ncidence of this debilitating complication. Intraoperative p

alpation of the aorta has been found to be insensitive foretecting and assessing the severity of the lesions [23].ransesophageal echocardiography has been demon-trated to be much more sensitive than palpation toetect ascending aorta atheromas [20]. During surgerypiaortic ultrasound has also been shown to predicttroke [22]. However, this technique is used only intra-peratively, whereas TEE is a safe and sensitive tool forreoperative assessment of thoracic aortic arteriosclero-is, identifying high-risk patients for stroke and helpingn the decision making and planning of different surgicalpproaches in this patient population. Moreover, it haseen shown that TEE-guided cannulation reduces mor-

ality and stroke [24]. Unlike patients with severe arterio-clerosis of the aorta who undergo coronary artery by-ass grafting, in whom off-pump techniques can be usedithout any manipulation of the aorta, in those who

equire AVR either aortic clamping or hypothermic cir-ulatory arrest is currently needed. In patients with ailder degree of aortic arch arteriosclerosis the uses of a

hort aortic cannula or a soft-flow cannula have beenntroduced with no perioperative stroke [25]. Severaleports on a small number of patients described differentechniques for managing aortic valve disease in patientsith severe aortic arch arteriosclerosis including a “no-

ouch” technique in which an alternative site for arterialannulation is chosen and AVR is performed underypothermic circulatory arrest [26, 27]. However, theuration of hypothermic circulatory arrest was long;

herefore, an alternative strategy such as aortic endarter-ctomy in patients with aortic arteriosclerosis has beenntroduced. This technique, however, has been nothown to prevent embolization [21]. Another methodsing balloon occlusion of the ascending aorta aftererforming an aortotomy with the use of hypothermicirculatory arrest for a brief time has been suggested, butemonstrated an increased risk for embolizations [28]. Inrecent study of 62 patients with severely arterioscleroticscending aortas who underwent AVR, five differenttrategies were used to manage the ascending aorta [29].hese techniques included AVR with the use of hypo-

hermic circulatory arrest (39%), ascending aortic endar-erectomy (26%), ascending aortic replacement (19%),ortic inspection and cross-clamping during hypother-ic circulatory arrest (10%), and balloon occlusion of the

scending aorta (6%). The postoperative death was 14%,nd 10 % experienced stroke. Although strokes wereimited to those with AVR with hypothermic circulatoryrrest and aortic endarterectomy, the choice of the oper-tive technique did not influence the risk of stroke.omplete AVR during hypothermic circulatory arrest

the “no-touch” technique) had required a prolongederiod of circulatory arrest. In this study authors con-luded that ascending aortic replacement is a preferredechnique, as it required a short period of hypothermicirculatory arrest and showed comparable mortality withlow risk of stroke.Degenerative AS has many similarities in the arterio-

clerotic plaque histology as well as many of the same

redisposing risk factors. Despite the similarities in clin-

itdSddsmoadssamttgtCatwTCssfc

CFdopeenranidRposlhdteln

CAsap

phas

R

1

1

1

1

1

1

1

1

118 GOLAND ET AL Ann Thorac SurgAORTIC ARTERIOSCLEROSIS IN AORTIC STENOSIS 2008;85:113–9

CA

RD

IOV

ASC

ULA

R

cal risk factors such as hypercholesterolemia or hyper-ension, others such as sex, diabetes, and endothelialysfunction have not been as strongly linked to AS [30].ome of the histopathologic findings associated withegenerative aortic valve disease and arteriosclerosis areifferent. For example, calcific changes, which can be alsoeen in arteriosclerotic plaques, occur earlier and areore prominent in calcific aortic valve disease [3]. More-

ver, in contrast to the gradual progression of degener-tive AS, acute plaque rupture can occur in CAD. Theseiscrepancies may help to explain the limited response totatin therapy in altering of aortic valve disease progres-ion compared with well-established efficacy on coronaryrtery plaque regression and reversal of carotid intimal-edial thickening by statins [31]. At present, based on

he available data there are no indications for statinherapy solely on the basis of AS alone if conventionaluidelines for statin therapy are not met [32–34]. Despitehe fact that both patient populations with AS and withAD were found to have strong association with aorticrteriosclerosis, it still remains unclear why some pa-ients with severe AS have normal coronary arteries andhether both CAD and AS are linked to aortic atheroma.he present study clearly demonstrates that coexistingAD in patients with AS appears to have an extremely

trong association with advanced thoracic aortic arterio-clerosis, whereas those without CAD had only a trendor higher prevalence of atheroma in the thoracic aortaompared with control subjects.

linical Implicationsrom our findings, several clinical implications can berawn. The presence of complex aortic arch atheromasn TEE appears be associated with an increased risk oferioperative stroke. A preoperative and intraoperativevaluation of the thoracic aorta should be considered,specially in patients having combined aortic and coro-ary disease. In selected patients with severe arterioscle-osis of the ascending aorta and aortic arch, coronaryrtery bypass grafting can be done without cardiopulmo-ary bypass, and alternative surgical approaches includ-

ng ascending aortic replacement or “no-touch” proce-ures without aortic clamping must be considered.ecently developed transapical surgical approach of im-lantation of a catheter-mounted valve combined withff-pump coronary artery bypass grafting is being pur-ued to reduce the risk of stroke in this high-risk popu-ation. Finally, it is not surprising that in patients with ASaving thoracic aorta atheromas, significant higher low-ensity lipoprotein levels were found compared with

hose who had no arteriosclerotic changes. However,ven in patients with atheroma the mean low-densityipoprotein level was less than 100 mg/dL, suggesting theeed for more aggressive treatment in this population.

onclusionsmong patients with severe AS, coexisting CAD is

trongly associated with the presence and severity ofrteriosclerotic changes in the thoracic aorta. Careful

resurgical evaluation and alternative approaches in

1

atients with combined AS and CAD, who represent aigh-risk population in terms of severe arteriosclerosisnd calcification of the ascending aorta, should be con-idered.

eferences

1. Selzer A. Changing aspects of the natural history of valvularaortic stenosis. N Engl J Med 1987;317:91–8.

2. Stewart BF, Siscovick D, Lind BK, et al. Clinical factorsassociated with calcific aortic valve disease. CardiovascularHealth Study. J Am Coll Cardiol 1997;29:630–4.

3. Otto CM, Kuusisto J, Reinchenbach DD, Gown AM, O’BrienKD. Characterization of the early lesion of “degenerative”valvular aortic stenosis: histologic and immunohistochemi-cal studies. Circulation 1994;90:844–53.

4. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS.Association of aortic valve sclerosis with cardiovascularmortality and morbidity in the elderly. N Engl J Med1999;341:142–7.

5. Tribouilly C, Peltier M, Colas L, Senni M, Ganry O, LesbreJP. Fibrinogen is an independent marker for thoracic aorticatherosclerosis. Am J Cardiol 1998;81:321–6.

6. Dressler FA, Craig WR, Castello R, Labovitz AJ. Mobileaortic atheroma and systemic emboli: efficacy of anticoagu-lation and influence of plaque morphology on recurrentstroke. J Am Coll Cardiol 1998;31:134–8.

7. Nihoyannopoulos P, Joshi J, Athansopoulog G, Oakley CM.Detection of atherosclerotic lesions in the aorta by trans-esophageal echocardiography. Am J Cardiol 1993;71:1208–12.

8. Pohle K, Popers D, Moshage W, Stilianakis N, Daniel WG,Achenbach S. Progression of aortic calcification: associationwith coronary atherosclerosis and cardiovascular risk fac-tors. Circulation 2001;104:1927–32.

9. Witteman JCM, Kannel WB, Wolf PA, et al. Aortic calcifiedplaques and cardiovascular disease (The FraminghamStudy). Am J Cardiol 1990;66:1060–4.

0. Agmon Y, Khandheria BK, Meissner I, et al. Aortic valvesclerosis and aortic atherosclerosis: different manifestationsof the same disease? J Am Coll Cardiol 2001;38:827–34.

1. Tunick PA, Rozenzweig BP, Katz ES, Freedberg RS, Perez JL,Kronzon I. High risk for vascular events in patients withprotruding aortic atheromas: a prospective study. J Am CollCardiol 1994;23:1085–90.

2. Mitusch R, Doherty C, Wucherpfenning H, et al. Vascularevents during follow-up in patients with aortic arch athero-sclerosis. Stroke 1997;28:36–9.

3. Cohen A, Tzourio C, Bertrand B, Chauvel C, Bousser MG,Amarenco P. Aortic plaque morphology and vascular events:a follow-up study in patients with ischemic stroke. FAPSInvestigators. French Study of Aortic Plaques in Stroke.Circulation 1997;96:3838–41.

4. Taniguchi H, Momiyama Y, Fayad ZA, et al. In vivo magneticresonance evaluation of associations between aortic athero-sclerosis and both risk factors and coronary artery disease inpatients referred for coronary angiography. Am Heart J2004;148:137–43.

5. Weisenberg D, Sahar Y, Sahar G, et al. Atherosclerosis of theaorta is common in patients with severe aortic stenosis: anintraoperative transesophageal echocardiographic study.J Thorac Cardiovasc Surg 2005;130:29–32.

6. Fazio GP, Redberg RF, Winslow T, Schiller NB. Transesoph-ageal echocardiographically detected atherosclerotic aorticplaque is a marker for coronary artery disease. J Am CollCardiol 1993;21:144–50.

7. Demopoulos LA, Tunick PA, Bernstein NE, Perez JL, Kro-nzon I. Protruding atheromas of the aortic arch in symptom-atic patients with carotid artery disease. Am Heart J 1995;129:40–4.

8. Kitaoka H, Okawa M, Kuwabara M, et al. Comparison ofthoracic aortic atherosclerotic plaque by echocardiography

1

2

2

2

2

2

2

2

2

2

2

3

3

3

3

3

I

TnvaageacwsSt

eamtaacsg

119Ann Thorac Surg GOLAND ET AL2008;85:113–9 AORTIC ARTERIOSCLEROSIS IN AORTIC STENOSIS

©P

CA

RD

IOV

ASC

ULA

R

in patients with stenotic tricuspid versus bicuspid aorticvalves. Am J Cardiol 2003;91:895–6.

9. Fayad ZA, Nahar T, Fallon JT, et al. In vivo magneticresonance evaluation of atherosclerotic plaques in the hu-man thoracic aorta: a comparison with transesophagealechocardiography. Circulation 2000;101:2503–9.

0. Katz ES, Tunick PA, Rusinek H, et al. Protruding aorticatheromas predict stroke in elderly patients undergoingcardiopulmonary bypass: a review of our experience withintraoperative transesophageal echocardiography. J Am CollCardiol 1992;20:70–7.

1. Stern A, Tunick PA, Culliford AT, et al. Protruding aortic archatheromas: risk of stroke during heart surgery with and with-out aortic arch endarterectomy. Am Heart J 1999;138:746–52.

2. Kronzon I, Tunick PA. Aortic atherosclerotic disease andstroke. Circulation 2006;114:63–75.

3. Wareing TH, Davila-Roman VG, Barzilai B, Murphy SF,Kouchoukos NT. Management of the severely atheroscle-rotic ascending aorta during cardiac operations: a strategyfor detection and treatment. J Thorac Cardiovasc Surg 1992;103:453–62.

4. Gold JP, Torres KE, Maldarelli W, Zhuravlev I, Condit D,Wasnick J. Improving outcomes in coronary surgery: theimpact of echo-directed aortic cannulation and perioperativehemodynamic management in 500 patients. Ann ThoracSurg 2004;78:1579–85.

5. Trehan N, Mishra M, Kasliwal RR, Mishra A. Surgical strate-gies in patients at high risk for stroke undergoing coronary

artery bypass grafting. Ann Thorac Surg 200;70:1037–45.

rafting, variations of “no touch” techniques, and re-

couapcnrt

A

CN5Ne

R

1

2008 by The Society of Thoracic Surgeonsublished by Elsevier Inc

6. Sabik JF, Nemeh H, Lytle BW, et al. Cannulation of theaxillary artery with a side graft reduces morbidity. AnnThorac Surg 2004;77:1315–20.

7. Byrne JG, Aranki SF, Cohn LH. Aortic valve operationsunder deep hypothermic circulatory arrest for the porcelainaorta: “no-touch” technique. Ann Thorac Surg 1998;65:1313–5.

8. Zingone B, Gatti G, Rauber E, Pappalardo A, Benussi B,Dreas L. Surgical management of the atherosclerotic ascend-ing aorta: is endoaortic balloon occlusion safe? Ann ThoracSurg 2006;82:1709–14.

9. Gillinov AM, Lytle BW, Hoang V, et al. The atheroscleroticaorta at aortic valve replacement: surgical strategies andresults. J Thorac Cardiovasc Surg 2000;120:957–63.

0. Freeman RV, Otto CM. Spectrum of calcific aortic valvedisease: pathogenesis, disease progression, and treatmentstrategies. Circulation 2005;111:3316–26.

1. Vaughan CJ, Gotto AM, Basson CT. The evolving role ofstatins in the management of atherosclerosis, J Am CollCardiol 2000;35:1–10.

2. Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trialof intensive lipid-lowering therapy in calcific aortic stenosis.N Engl J Med 2005;352:2389–97.

3. Moura LM, Ramos SF, Zamorano JL, et al. Rosuvastatinaffecting aortic valve endothelium to slow the progression ofaortic stenosis, J Am Coll Cardiol 2007;49:554–61.

4. Griffin BP. Statins in aortic stenosis: new data from a

prospective clinical trial. J Am Coll Cardiol 2007;49:562–4.

NVITED COMMENTARY

his study [1] is both timely and pertinent. Increasingumbers of elderly patients are now undergoing aorticalve surgery, many of whom have significant coronaryrtery disease. In this study the mean age was 75 yearsnd 60% required both valve replacement and bypassrafting. A careful intraoperative transesophagealchocardiography study demonstrated that serioustheroma was present in nearly 2 of 3 patients withombined valve and coronary artery disease, whichas much higher than that for patients with only aortic

tenosis or those who were in a control cohort group.imilar findings were noted when aortic root calcifica-

ion was studied.The significant finding was a stroke rate of 4.7% in the

ntire series; however, among 35 patients with complexrch atheroma (ie, thicker plaque with protrusion ofobile debris or ulceration, or both) the stroke rate

ripled to 16%. Therefore, these findings serve as a call toction in re-evaluating our management strategy. Theuthors note that such strategies may include axillaryannulation, less traumatic cannula tips, balloon occlu-ion, soft cross clamps, circulatory arrest with aorta

ently introduced transapical valve replacement withff-pump grafting. Although these maneuvers were notsed in this retrospective study, it is reasonable tossume that the stroke rate should decrease with appro-riate application. This is an important article that meritsareful study. Increasing numbers of elderly patients areow undergoing aortic valve surgery, and in those whoequired bypass grafting, severe aortic atherosclerosis ishe rule not the exception.

lfred Culliford, MD

ardiothoracic SurgeryYU Medical Center

30 First Ave, Suite 9-Vew York, NY 10016

-mail: [email protected]

eference

. Goland S, Trento A, Czer LSC, et al. Thoracic aortic arterio-sclerosis in patients with degenerative aortic stenosis withand without coexisting coronary artery disease. Ann Thorac

Surg 2008;85:113–9.

0003-4975/08/$34.00doi:10.1016/j.athoracsur.2007.09.042